Our market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh...
Read moreWebinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...
Read moreOur experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...
Read moreThe Haute Autorité de Santé (HAS), recently announced changes to the conditions in which a drug wi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreIt is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...
Read moreThe aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.
Read moreEUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreTwo NICE teams (NICE International and the Science Policy and Research Programme) will act as key en...
Read more